Best Supplements to Take With Retatrutide + Cagrilintide

Four Receptors, One Stack, and a Nutritional Gap That Runs Deeper Than Most

Most weight-loss peptides work by turning down one dial. Semaglutide pulls on the GLP-1 receptor and appetite falls. Tirzepatide adds the GIP receptor and pulls on two. Retatrutide and cagrilintide together pull on four completely separate receptor pathways simultaneously, and that changes the supplement conversation in ways that do not apply to anything else in this class.

Retatrutide binds three receptors at the same time: GLP-1, GIP, and glucagon. The GLP-1 and GIP arms handle appetite and insulin signaling, the same mechanism shared with the rest of the family. The glucagon arm is what separates this compound. When the glucagon receptor is activated, the body burns more calories at rest and pulls fat from the liver more aggressively for fuel. That calorie-burning effect is completely absent in semaglutide and tirzepatide, and it is a primary reason retatrutide's weight-loss results in clinical trials have exceeded both.

Cagrilintide adds a fourth pathway through an entirely different system. It is a synthetic version of amylin, a hormone the pancreas releases alongside insulin. It binds amylin receptors in a region of the brainstem called the area postrema, reaching a satiety center that the incretin drugs cannot touch. That brainstem route is entirely separate from the hypothalamic pathways that GLP-1 drugs use, which is why combining it with retatrutide produces appetite suppression greater than either compound produces alone.

The practical consequence of four active pathways pulling simultaneously is a calorie intake drop that is, in clinical terms, steep: anywhere from forty to sixty percent below baseline in typical protocols. Calories fall. Protein falls. Every micronutrient that arrives packaged in food falls with them. The body's requirements for those micronutrients do not move. That gap, between what someone on this stack is eating and what their physiology still needs, is the problem this supplement guide exists to close.

One additional wrinkle specific to retatrutide has no equivalent in semaglutide or tirzepatide. When the glucagon receptor is activated, it signals the liver to break down amino acids for energy. That is a direct, ongoing drain on the protein pool available for muscle repair and maintenance, running on top of the caloric deficit that already makes muscle preservation difficult. The protein argument on this combination is therefore more urgent than it is on any drug that targets only one or two receptors, and it is a reason that comes from retatrutide's specific pharmacology rather than from a generic statement about weight loss.

Neither compound is commercially approved as of 2026, and the combination carries no finalized published clinical trial data. Everything in this guide applies within that experimental context.

The Supplements That Matter Most on This Stack

There are no dose amounts on this page, and that is deliberate rather than an oversight. The right amount of each supplement depends on your specific protocol, where your bloodwork sits, and what you are already taking. A number printed for the average reader is wrong for most specific people. MyPeptidePal takes your inputs and produces a personalized plan from them.

The Micronutrient Gap This Combination Creates

This stack suppresses appetite more aggressively than any single approved agent in the class, which means the micronutrient shortfalls that develop quietly on semaglutide develop faster and run deeper here. Correcting these before attributing poor energy or slow results to the peptides themselves is one of the highest-value things a person running this combination can do.

Vitamin D

Vitamin D deficiency is common in the population this medication targets. Obesity independently raises the risk because vitamin D is fat-soluble and gets sequestered in adipose tissue, drawn away from circulation. When caloric restriction cuts food intake by half, dietary vitamin D falls proportionally. The result is that a significant share of people starting this combination are already deficient, and the deficit widens as the protocol progresses.

What makes this more than a background concern on this specific stack is magnesium's role in vitamin D activation. Vitamin D must be converted from its storage form into an active form before the body can use it, and the enzyme that runs that conversion requires magnesium. A person who is both vitamin D deficient and magnesium deficient is supplementing vitamin D into a system that cannot finish processing it. Both have to be addressed at the same time.

The bloodwork marker that matters is 25-OH-D, the storage form measured in circulation. Testing before supplementing is worth the step because the gap between mild and severe deficiency is wide enough to determine how much correction is actually needed.

Vitamin B12

B12 is found almost exclusively in animal products. When aggressive appetite suppression substantially cuts overall intake, and particularly when it reduces meat, dairy, and egg consumption, B12 is one of the first deficiencies to emerge. It does not emerge loudly. Fatigue is the most common early symptom, and fatigue is already present from the caloric restriction itself, which means B12 deficiency gets attributed to the protocol and goes uncorrected.

Left long enough, B12 deficiency causes neurological symptoms and elevated homocysteine. Homocysteine is a protein byproduct that accumulates when B12 and folate status are inadequate and can be tracked as a marker of functional B12 insufficiency even when serum B12 appears borderline. Methylmalonic acid, a more sensitive marker of how well B12-dependent enzymes are actually working, gives a fuller picture than serum B12 alone.

Methylcobalamin is the active form and does not require the conversion step that cyanocobalamin needs, which matters when the goal is genuine repletion.

Multivitamin

A broad multivitamin is not an exciting recommendation, and the evidence for one in a healthy person eating adequate calories is modest. This situation is different. A forty to sixty percent calorie reduction does not selectively spare any particular micronutrient. Zinc, folate, thiamine, riboflavin, selenium, and several others fall proportionally with food intake, and addressing all of them with individual supplements becomes unwieldy quickly.

A multivitamin taken alongside the targeted supplements in this guide fills the micronutrient floor that targeted supplementation cannot reach economically. The evidence supporting this approach in the context of severe caloric restriction comes primarily from the bariatric surgery literature, which produces nutritional conditions similar to aggressive GLP-1 therapy. It is not a substitute for the specific supplements on this list; it is the safety net underneath them.

Iron

Iron requires a different approach from the other deficiency-gate supplements because the consequences of supplementing without confirmed deficiency are real. Too much iron is pro-oxidant and disrupts zinc and copper absorption. The right sequence is testing ferritin first, then deciding.

The reason iron lands on this list is that its deficiency symptoms, fatigue, reduced exercise capacity, and hair shedding, are exactly what people on a demanding weight-loss protocol tend to blame on the protocol. The protocol may be a contributing factor. Iron deficiency is a correctable one, and correcting it can restore the energy and exercise tolerance needed to preserve lean mass through resistance training.

Iron deficiency is particularly common in people who were already at marginal stores before starting, including a large share of premenopausal women and anyone eating a low-meat diet. The rapid intake drop this stack produces can push marginal stores into frank deficiency within weeks.

One timing note specific to this combination: iron absorption normally depends on an acidic gastric environment. The slower transit that retatrutide and cagrilintide both produce shifts the timing of that environment. For anyone with significant GI symptoms, the absorption dynamics are less reliable than in a person with normal gastric motility, which is worth discussing with a clinician if iron repletion is needed.

What Three Simultaneous Mechanisms Do to the Stomach, and What Helps

The nausea on this combination is not the same as the nausea on semaglutide, and treating it identically misses what makes it worse. On semaglutide, one mechanism slows the stomach: GLP-1 receptor activation reduces gastric motility as part of its appetite-suppressing effect. On retatrutide plus cagrilintide, three mechanisms slow it simultaneously. The GLP-1 arm contributes its usual effect. The glucagon arm adds a catecholamine-like influence on GI motility. And cagrilintide's amylin-driven gastric-emptying delay acts from the brainstem through a pathway entirely separate from the other two. Clinical trials reported nausea in up to sixty percent of participants at higher retatrutide doses. The constipation, cramping, and fluid loss that follow are predictable consequences of the same combined GI slowdown.

Because gastric emptying is slowed chronically across the whole week rather than just in the hours after a single injection, supplement absorption is affected throughout, not just on injection day. This is different from a daily-dosed compound where timing supplements around a single window is straightforward. On a weekly protocol with three converging mechanisms, the altered GI environment is persistent, which is particularly relevant for fat-soluble vitamins and iron, both of which depend on gastric conditions for absorption.

Ginger

Ginger has more direct human trial evidence behind it for nausea than almost anything else on this list. It has been tested in randomized controlled trials for chemotherapy-induced nausea and postoperative nausea, where it produced meaningful reductions in symptom severity. Its use for GLP-1-driven nausea is an extension of that evidence base rather than a directly studied application, but the underlying mechanisms are the same.

Ginger works by blocking specific signaling switches involved in the urge to vomit, including the 5-HT3 receptor, a switch located in the gut and brainstem that prescription antiemetics also target. Animal and small human studies also suggest ginger may gently encourage food to move forward through the lower stomach. In a context where three separate mechanisms are slowing gastric transit, any safe nudge toward normal motility carries additional value on top of the direct nausea relief.

For a combination that produces nausea in the majority of users during dose escalation, ginger is the first supplement to reach for. It has the strongest evidence, the clearest mechanism, and no meaningful interaction with either peptide.

Vitamin B6

Vitamin B6 addresses nausea through a completely different mechanism from ginger, which is precisely what makes adding it worthwhile rather than choosing between them. B6 works by influencing dopamine and serotonin signaling in the brain regions responsible for the nausea response, rather than targeting the peripheral gut receptors that ginger acts on. The clinical evidence for B6 as an antiemetic comes primarily from pregnancy-related nausea research, where it has randomized trial support.

The evidence for B6 specifically in the context of GLP-1 or amylin-driven nausea is limited to community use and mechanistic reasoning rather than direct trials. That is an honest description of what exists. Ginger carries the stronger evidence base. B6 is a reasonable companion through a separate pathway, with its status clearly understood.

Magnesium

Magnesium is the double-duty supplement on this list, earning its slot on two separate grounds. On the deficiency side, it is required for the enzyme that converts vitamin D from its storage form into its active form. Low magnesium means vitamin D supplementation produces less result than expected, regardless of how much is taken. On the side-effect side, magnesium in the right form relieves the constipation that three converging gastric-slowing mechanisms create, without adding the GI disruption of harsher interventions.

The form matters directly for the GI situation this stack creates. Magnesium oxide and citrate work partly by drawing water into the gut, which produces a laxative effect. On a protocol already causing nausea and GI stress, that effect is counterproductive. Magnesium glycinate is absorbed through a different pathway that does not rely on osmotic action in the gut, making it well tolerated even in people managing significant GI side effects.

The marker that reflects true magnesium status is RBC magnesium, measured inside red blood cells rather than in serum. Serum magnesium is tightly regulated by the body and stays within the normal range until deficiency is severe. RBC magnesium shows what is actually stored in cells.

Soluble Fiber (Psyllium)

Constipation is a predictable and persistent side effect of this combination. Psyllium husk, a soluble fiber that dissolves in water and forms a gel in the intestine, relieves constipation by adding bulk and drawing water into the stool, which eases passage without the cramping that stimulant laxatives cause.

The timing guidance is genuinely important and reflects real clinical experience: do not introduce fiber in the first week of a new dose step-up. During the earliest phase of titration, nausea is at its peak and the stomach is already under stress. Adding bulk to an already-slowed system compounds the discomfort in ways that can make GI side effects temporarily worse. Once nausea has settled to a background level, which typically takes one to two weeks at each new dose, psyllium becomes a useful and well-tolerated tool for the constipation that remains.

Adequate hydration is not optional with psyllium. It absorbs liquid aggressively, and taken without enough water it can cause obstruction rather than relief. This is particularly relevant on a protocol that already raises dehydration risk through nausea and reduced fluid intake.

Electrolytes

When nausea causes vomiting and food intake drops by half, sodium and potassium are the first electrolytes to fall. Both are lost directly through vomiting, and both arrive primarily through food, which is now substantially reduced. The downstream effects, fatigue, muscle cramps, and headaches, are easy to mistake for peptide side effects rather than a correctable problem.

One consideration specific to retatrutide that does not apply to semaglutide or tirzepatide: the glucagon arm raises resting heart rate, a cardiovascular effect tied to glucagon receptor activation. Significant electrolyte imbalances, particularly low potassium, independently affect cardiac rhythm. On a compound that already elevates heart rate through this mechanism, maintaining electrolyte balance has a cardiovascular dimension that is worth taking seriously.

A comprehensive metabolic panel covers the main electrolytes alongside kidney function, which is relevant because dehydration from GI fluid loss puts additional pressure on the kidneys. Running one at baseline and repeating it if significant vomiting or diarrhea occurs gives the clearest picture of where losses are happening.

Blood Sugar Support Through a Different Door

Berberine

Berberine is a plant-derived compound with a well-characterized cellular mechanism. It activates an enzyme called AMPK, which acts like a fuel gauge inside cells: when AMPK is switched on, cells become more responsive to insulin, glucose uptake improves, and the liver reduces its output of glucose into the bloodstream. The blood sugar effect is meaningful and has been compared to metformin in human trials, operating through overlapping mechanisms at the cellular level.

The reason berberine belongs specifically on a retatrutide plus cagrilintide stack, rather than being a generic glucose-support recommendation, comes from the glucagon component of retatrutide. When the glucagon receptor is activated, it raises blood glucose as part of its energy-mobilization effect. Retatrutide's GLP-1 and GIP arms counteract this through insulin stimulation, and in trial data the net glucose effect is favorable. But in the context of aggressive caloric restriction with liver glucose metabolism already responding to glucagon signals, a tool that independently improves insulin sensitivity through AMPK has a coherent mechanistic place that it does not have on a compound targeting only GLP-1.

The caution here is significant and belongs front of mind rather than in fine print. Berberine's glucose-lowering effect is additive with these peptides. In someone also taking exogenous insulin or a sulfonylurea, that additive burden can push blood glucose into genuinely dangerous territory. Anyone on those medications needs clinical guidance before adding berberine, and more frequent blood glucose monitoring becomes important once it is in the stack. The evidence for berberine in glucose regulation is drawn from human trials, though most were conducted in diabetic populations rather than in people specifically on this drug combination. Its use here is extrapolated from mechanism and community experience.

What Keeps the Weight Loss From Costing You Muscle

Weight lost on this combination is not all fat. Clinical data from retatrutide trials shows that roughly twenty to twenty-five percent of total weight lost is lean mass, comparable to tirzepatide. That fraction is not fixed. It responds to protein intake and resistance training, and the supplements in this section are specifically positioned to move it.

Protein (Whey or Plant-Based)

Protein intake is the single highest-leverage nutritional variable for muscle preservation during weight loss. Muscles are built from amino acids, and the signal that tells the body to maintain them requires a regular supply of those amino acids, particularly leucine, to exceed a threshold that triggers muscle protein synthesis. Fall below that threshold consistently and the body has no reason to hold tissue it can use for fuel.

The challenge on this stack is appetite suppression severe enough that many people genuinely cannot eat enough protein through food alone. The stomach feels full long before protein targets are reached. A concentrated protein source in a small volume allows adequate intake even when total food volume is very low.

The glucagon arm of retatrutide creates an additional argument for higher protein intake that does not apply to semaglutide or tirzepatide. When the glucagon receptor is activated, the liver is directed to break down amino acids for energy. More amino acids being routed toward fuel means the pool available for muscle repair is smaller. Higher protein intake compensates for that added drain, and this mechanism is specific to retatrutide's triple-receptor pharmacology rather than a feature of GLP-1 therapy generally.

The evidence for protein's role in lean mass preservation during caloric restriction is among the most robust in nutritional science, supported by multiple randomized trials across diverse populations.

Creatine Monohydrate

Creatine is the most evidence-backed sports nutrition compound for preserving muscle and strength during a caloric deficit, and that evidence spans hundreds of trials across athletic and non-athletic populations. Its primary mechanism involves replenishing the short-term energy stores muscles draw on during high-intensity exercise like resistance training. More available energy means better performance during the workouts that provide the mechanical signal necessary for muscle retention.

Beyond the exercise-performance pathway, creatine has direct effects on muscle protein synthesis signaling through separate mechanisms studied in populations ranging from trained athletes to older adults experiencing muscle loss. The totality of that evidence makes creatine one of the few supplements with widespread clinical support for this specific purpose.

One practical note for anyone monitoring labs: creatine raises serum creatinine, a routine kidney function marker, by a small amount without causing actual kidney damage. Informing the ordering clinician about creatine use before kidney function labs avoids unnecessary concern or follow-up testing.

Hydration matters more with creatine in this context. Creatine draws water into muscle cells, and fluid balance is already under pressure from GI-related losses on this combination.

HMB

HMB, which stands for beta-hydroxy beta-methylbutyrate, is a compound the body produces in small amounts from the amino acid leucine. Its mechanism targets the breakdown side of the muscle-balance equation rather than the building side. During rapid weight loss, the signals telling the body to break down muscle tissue are elevated. HMB works by directly blocking part of that breakdown pathway at the cellular level.

The glucagon arm of retatrutide adds a layer of amino acid drain that compounds this breakdown pressure. The liver's increased demand for amino acids as fuel, driven by glucagon receptor activation, pulls from the same pool that muscle maintenance draws on. That double pressure, catabolic signaling from caloric restriction plus ongoing hepatic amino acid consumption from the glucagon arm, is more acute on this combination than on a dual-agonist like tirzepatide that carries no glucagon component. HMB's anti-breakdown mechanism addresses that specific burden directly.

The evidence for HMB is genuinely mixed and deserves an honest description. In populations under significant catabolic stress, including older adults with muscle-wasting conditions and people undergoing aggressive caloric restriction, human trials show meaningful effects on lean mass retention. In well-nourished athletes in a modest deficit, the effects are smaller and less consistent. The retatrutide plus cagrilintide context, with aggressive intake suppression layered on top of the glucagon arm's amino acid drain, sits closer to the former scenario. That is the mechanistic argument for including it, not a guarantee of effect.

Biotin

Hair shedding is among the most visible and distressing secondary effects of rapid weight loss, and it is frequently reported during aggressive weight-loss therapy. The mechanism is nutritional stress on metabolically demanding tissue. Hair follicles are among the most active tissues in the body and among the first to suffer when the nutrient supply drops sharply.

Biotin is a B vitamin required for the production of keratin, the structural protein that makes up hair. It is reasonably abundant in a varied diet, but the forty to sixty percent calorie reduction this combination produces, steeper than what most people experience on semaglutide alone, can bring intake to levels where follicle function is affected. The scale of suppression here matters: a ten to fifteen percent calorie reduction is unlikely to stress keratin production meaningfully, but a forty to sixty percent reduction is a different situation. The evidence for biotin specifically for hair in the context of rapid weight loss draws from observational data and user-reported experience rather than controlled trials. That is an honest description of the support level.

Collagen Peptides

Rapid weight loss removes the fat and connective tissue support beneath skin quickly, and the more aggressive the loss the more acute that structural change is. Collagen peptides provide glycine, proline, and hydroxyproline, the amino acids that form the structural framework of connective tissue in skin. Several small randomized trials in humans have tested collagen peptides for skin structure with positive results, making this the better-evidenced of the two appearance-related supplements on this list.

On this combination specifically, the scale of calorie suppression, again that forty to sixty percent range, concentrates the nutritional stress on skin more than a milder protocol would. Dietary collagen provides building blocks for maintaining skin integrity through a transition that happens faster and cuts deeper than most weight-loss approaches.

Cautions and Interactions

Hypoglycemia risk with insulin and sulfonylureas. This is the most serious interaction on this stack and must lead any clinical conversation about medications and supplements. Retatrutide's GLP-1 and GIP receptor activity lowers blood glucose through insulin stimulation and glucagon suppression. Berberine adds a further glucose-lowering effect through AMPK activation. In someone also taking exogenous insulin or a sulfonylurea, the combined burden can push blood sugar into genuinely dangerous territory. This is a recognized interaction class, not a theoretical concern. Anyone on insulin or a sulfonylurea should not add berberine without clinical guidance and should be monitoring glucose more closely than the peptides alone would require.

Introduce fiber gradually, not immediately. Adding psyllium during the peak nausea period of a new dose step-up, typically the first week at each titration level, compounds GI discomfort in a system already under significant stress. Start at a lower amount after nausea has settled and increase slowly. Too much fiber introduced too soon is one of the more reliable ways to make the GI side-effect burden temporarily worse.

Hydration and creatine. Creatine is osmotically active and draws water into muscle cells. On a protocol where nausea and vomiting already elevate fluid losses, adding creatine without increasing water intake puts extra demand on fluid balance that is already under pressure.

Do not combine with other GLP-1 agonists. Adding semaglutide or tirzepatide on top of this combination creates redundant receptor binding with no additional clinical benefit and substantially worsened GI toxicity.

Warfarin and other anticoagulants. Delayed gastric emptying from this combination alters the absorption timing of oral medications, including anticoagulants like warfarin, which has a narrow therapeutic range where small changes in absorption produce clinically significant changes in effect. Ginger also carries mild antiplatelet activity at higher amounts. Anyone on an anticoagulant should discuss both the peptide combination and any new supplements with the prescriber managing their anticoagulation.

High potassium supplements with ACE inhibitors or potassium-sparing diuretics. Both drug classes are common in the cardiovascular and hypertensive patient population that frequently overlaps with the people using this combination. Adding potassium-containing electrolyte supplements on top of medications that retain potassium can push serum levels to dangerous concentrations. Review all cardiovascular medications before adding electrolyte supplements.

Pancreatitis history. Both retatrutide and cagrilintide individually carry pancreatitis warnings. The combination's pancreatic risk profile is not characterized in published data. Anyone with a history of pancreatitis should not use this combination.

This combination is not commercially approved. There is no finalized published clinical trial data for the retatrutide plus cagrilintide combination as of 2026. All use outside of authorized clinical trials is experimental, and the supplement considerations in this guide apply within that context.

Frequently Asked Questions

How much of each supplement should I take with Retatrutide and Cagrilintide?

There are no dose amounts on this page, and that is intentional. The right amount of each supplement depends on your specific protocol, your current bloodwork, your body weight, and what else you are taking. Supplements like iron and vitamin D require knowing where your labs actually sit before a sensible amount can be determined. Others, like protein, scale with your goal body weight rather than any single figure that applies across everyone. MyPeptidePal takes your inputs and builds a personalized plan from them, which is the version that reflects your situation rather than an average.

Which blood markers matter most when running this combination?

The most important baseline panel covers ferritin for iron status, 25-OH-D for vitamin D, serum B12, RBC magnesium, a comprehensive metabolic panel for electrolytes and kidney function, and a fasting glucose given the glucagon arm's effect on blood sugar. If berberine is added, glucose monitoring becomes more important, not optional. Retatrutide improves triglycerides and non-HDL cholesterol, so a lipid panel at baseline and after a few months gives useful data on how the compound itself is affecting your metabolic picture alongside the supplements.

Do any of these supplements interfere with how the peptides work?

None of the supplements on this list directly block or work against the GLP-1, GIP, glucagon, or amylin receptors that these compounds act on. The concern that applies runs in the other direction: berberine adds to the glucose-lowering effect rather than counteracting it, which matters if insulin or a sulfonylurea is also in the picture. Psyllium and iron taken at the same time as other oral medications can affect absorption timing for those medications, so spacing them two or more hours from other drugs is good practice.

Do I need to keep taking these after stopping the combination?

The supplements addressing deficiencies created by caloric restriction, vitamin D, B12, iron, and the multivitamin, are needed as long as intake is significantly suppressed. Once food intake returns to normal after stopping the protocol, most people can phase out targeted supplementation and recheck labs to confirm stores have recovered. Protein and creatine have benefits that extend well beyond any specific peptide protocol, particularly for anyone who has built a resistance training practice to preserve lean mass, and many people continue them as part of a long-term maintenance approach. The side-effect supplements can be discontinued once the side effects are no longer present.

Can I just eat well instead of supplementing on this combination?

Food first is the right principle in most nutritional contexts, and whole foods carry cofactors and fiber that supplements do not fully replicate. The honest answer specific to this combination is that meeting micronutrient needs through food on a forty to sixty percent calorie reduction is practically very difficult for most people, and especially so when nausea is present and eating is unpleasant. The appetite suppression this stack produces is among the most aggressive of any weight-loss medication, which is exactly what makes it effective. That efficacy creates the nutritional gap that supplementation addresses. Eating as well as possible within what the protocol allows remains the right foundation. These supplements exist to close the gap that food alone cannot bridge at this level of intake reduction.

This content is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment recommendations. MyPeptidePal is not a medical provider. Always consult a qualified healthcare professional before starting, modifying, or stopping any health protocol, supplement regimen, or therapeutic intervention.

Sources

The information in this guide is drawn from the MyPeptidePal knowledge base, which brings together published research, clinical data, and documented real-world use of retatrutide and cagrilintide and the nutrients that support them in one place.